Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.
Tris Pharma, Inc. v. Teva Pharmaceuticals USA, Inc.
Opinion
Case: 23-1158 Document: 5 Page: 1 Filed: 12/14/2022
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit ______________________ TRIS PHARMA, INC., Plaintiff-Appellee v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant ______________________ 2023-1158 ______________________ Appeal from the United States District Court for the District of New Jersey in No. 2:20-cv-05212-KM-ESK, Judge Kevin McNulty. ______________________ ON MOTION ______________________ ORDER Teva Pharmaceuticals USA, Inc. moves to voluntarily dismiss this appeal pursuant to Rule 42 of the Federal Rules of Appellate Procedure, stating that “[n]o costs are due” and that Tris Pharma, Inc. does not oppose the mo- tion. Mot. at 1.
Upon consideration thereof, Case: 23-1158 Document: 5 Page: 2 Filed: 12/14/2022
2 TRIS PHARMA, INC. v. TEVA PHARMACEUTICALS USA, INC.
IT IS ORDERED THAT: (1) The motion is granted. The appeal is dismissed. (2) The parties shall bear their own costs.
FOR THE COURT December 14, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court
ISSUED AS A MANDATE: December 14, 2022
Case-law data current through December 31, 2025. Source: CourtListener bulk data.